Samuel Hume, Fellow at The Foulkes Foundation and pursuing a PhD in the University of Oxford’s Department of Oncology, shared a post on X:
“5 clinical trials to watch in 2026.
Ras inhibition in pancreatic cancer, new approaches for prevention of heart disease, Retatrutide vs. Tirzepatide for obesity, and a next-generation antibody in Alzheimer’s disease
Read it here.”
More posts featuring Samuel Hume.